Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

XUJ4:GR

541.1500 EUR 8.5860 1.61%

As of 09:59:18 ET on 05/27/2015.

Snapshot for Candriam Equities L Biotechnology (XUJ4)

Open: 551.5730 High - Low: 551.5730 - 530.0000 Primary Exchange: Berlin
Volume: 11 52-Week Range: 271.8120 - 578.0540 Beta vs BTK: 0.9470

ETF Chart for XUJ4

No chart data available.
  • XUJ4:GR 542.9780
  • 1D
  • 1M
  • 1Y
532.5640
Interactive XUJ4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XUJ4

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 2000-04-06 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for XUJ4

NAV -
Assets (M) (on 2015-05-22) 832.3654
Shares out (M) 0.76
Market Cap (M) 403.24
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for XUJ4

No dividends reported

Performance for XUJ4

1-Month -3.03% 1-Year +94.90%
3-Month +6.80% 3-Year +47.62%
Year To Date +26.87% 5-Year +34.50%
Expense Ratio 1.77

Top Fund Holdings for XUJ4

Filing Date: 03/31/2015
Name Position Value % of Total
Biogen Inc 164,000 69,247,360 8.171%
Gilead Sciences Inc 630,000 61,821,900 7.295%
Celgene Corp 530,000 61,098,400 7.209%
Amgen Inc 369,000 58,984,650 6.960%
Regeneron Pharmaceuticals Inc 111,500 50,340,020 5.940%
Alexion Pharmaceuticals Inc 175,000 30,327,500 3.578%
BioMarin Pharmaceutical Inc 198,000 24,674,760 2.911%
Vertex Pharmaceuticals Inc 200,000 23,594,000 2.784%
Incyte Corp 240,000 21,998,400 2.596%
Illumina Inc 95,000 17,635,800 2.081%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil